See more : Mebuki Financial Group, Inc. (7167.T) Income Statement Analysis – Financial Results
Complete financial analysis of SS Innovations International, Inc. (SSII) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of SS Innovations International, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- Gandhi Special Tubes Limited (GANDHITUBE.BO) Income Statement Analysis – Financial Results
- Takamisawa Cybernetics Company, Ltd. (6424.T) Income Statement Analysis – Financial Results
- INEST, Inc. (7111.T) Income Statement Analysis – Financial Results
- Mary Agrotechnologies Inc. (MRRYF) Income Statement Analysis – Financial Results
- Ondas Holdings Inc. (ONDS.TA) Income Statement Analysis – Financial Results
SS Innovations International, Inc. (SSII)
About SS Innovations International, Inc.
SS Innovations International, Inc. develops surgical robotic systems. It also develops SSI Mantra, a surgical robotic system; SSI Mudra, a range of surgical instruments that supports in surgical procedures, including robotic cardiac surgery; SSI Maya, a robotic surgery platform; and OMNI 3D HD provides live 3D HD view of the surgical field in robotic surgery operating room. The company is based in Fort Lauderdale, Florida.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 5.88M | 1.46M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 5.17M | 968.72K | 18.79K | 37.43K | 37.70K | 19.46K | 789.00 | 0.00 |
| Gross Profit | 713.45K | 489.59K | -18.79K | -37.43K | -37.70K | -19.46K | -789.00 | 0.00 |
| Gross Profit Ratio | 12.13% | 33.57% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 576.17K | 83.28K | 1.00K | 3.00K | 60.87K | 27.13K | 71.17K | 138.38K |
| General & Administrative | 20.81M | 6.09M | 1.41M | 1.10M | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | -18.79K | -37.43K | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 20.81M | 6.09M | 1.39M | 1.06M | 3.22M | 913.79K | 938.85K | 324.12K |
| Other Expenses | 0.00 | 279.98K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 21.38M | 6.17M | 1.39M | 1.07M | 3.28M | 940.92K | 1.01M | 462.49K |
| Cost & Expenses | 26.55M | 7.14M | 1.41M | 1.10M | 3.32M | 960.38K | 1.01M | 462.49K |
| Interest Income | 129.76K | 239.73K | 118.00 | 6.00 | 0.00 | 58.00 | 84.00 | 31.00 |
| Interest Expense | 523.36K | 162.00K | 0.00 | 1.06K | 0.00 | 0.00 | 27.00K | 22.52K |
| Depreciation & Amortization | 162.62K | 128.90K | 18.79K | 37.43K | 37.70K | 19.46K | 789.00 | 0.00 |
| EBITDA | -20.26M | -5.31M | -1.47M | -1.09M | -3.33M | -940.86K | -1.01M | -462.46K |
| EBITDA Ratio | -344.51% | -380.60% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -20.67M | -5.68M | -1.41M | -1.10M | -3.32M | -960.38K | -1.01M | -462.49K |
| Operating Income Ratio | -351.52% | -389.44% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -273.60K | 77.73K | -77.27K | -21.75K | -63.29K | 58.00 | -26.91K | -22.49K |
| Income Before Tax | -20.94M | -5.60M | -1.48M | -1.12M | -3.39M | -960.32K | -1.04M | -484.98K |
| Income Before Tax Ratio | -356.17% | -384.11% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 0.00 | 3.00 | -1.00 | -2.00 | -3.00 | 2.00 | 0.00 |
| Net Income | -20.94M | -5.60M | -1.48M | -1.12M | -3.39M | -960.32K | -1.04M | -484.98K |
| Net Income Ratio | -356.17% | -384.11% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.16 | -0.14 | -0.52 | -0.48 | -1.57 | -0.46 | -0.53 | -0.25 |
| EPS Diluted | -0.16 | -0.14 | -0.52 | -0.48 | -1.57 | -0.46 | -0.53 | -0.25 |
| Weighted Avg Shares Out | 128.45M | 40.88M | 2.85M | 2.34M | 2.15M | 2.09M | 1.95M | 1.92M |
| Weighted Avg Shares Out (Dil) | 128.45M | 40.88M | 2.85M | 2.34M | 2.15M | 2.09M | 1.95M | 1.92M |
SS Innovations Engages BDO as its new Auditor
SS Innovations believes that the selection of BDO will facilitate uplisting of its common stock to a National Securities Exchange and reflects the Company's commitment to transparent financial and accounting practices and regulatory compliance FORT LAUDERDALE, Fla., May 31, 2024...
SS Innovations Engages BDO as its new Auditor
FORT LAUDERDALE, Fla., May 31, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making world class robotic surgery affordable and accessible to a global...
SS Innovations' SSi Mantra Surgical Robotic System Used to Perform 100 Cardiac Surgeries, Signaling Market Expansion
FORT LAUDERDALE, FL, May 21, 2024 – SS Innovations International, Inc.
SS Innovations Achieves Pediatric Milestone with First Infant Pyeloplasty Using SSi Mantra Surgical Robotic System
Company's flagship SSi Mantra surgical device has now been used in more than 1000 procedures FORT LAUDERDALE, FL, April 29, 2024 – SS Innovations International, Inc.
SS Innovations International Announces Q1 2024 Company Updates
Significant milestones achieved for SSi Mantra Made-in-India surgical robotic system FORT LAUDERDALE, Fla., April 22, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making...
SS Innovations International Announces Q1 2024 Company Updates
Significant milestones achieved for SSi Mantra Made-in-India surgical robotic system FORT LAUDERDALE, FL, April 22, 2024 – SS Innovations International, Inc.
SS Innovations' Flagship SSi Mantra Surgical Robotic Device Successfully Completes Telesurgery Procedures
First-ever telesurgery using SSi Mantra performed on an animal in India FORT LAUDERDALE, FL, April 10, 2024 – SS Innovations International, Inc.
SS Innovations' Flagship SSi Mantra Surgical Robotic Device Successfully Completes Telesurgery Procedures
FORT LAUDERDALE, Fla., April 10, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making world class robotic surgery affordable and accessible to a global...
SS Innovations' SSi Mantra Surgical Robotic System used to perform Mitral Valve Replacement
The first Mitral Valve Replacement using the Made in India SSi Mantra Surgical Robotic System was successfully performed at the Narayana Institute of Cardiac Sciences in Bengaluru, India FORT LAUDERDALE, FL, March 12, 2024 – SS Innovations International, Inc.
SS Innovations' SSi Mantra Surgical Robotic System used to perform Mitral Valve Replacement
FORT LAUDERDALE, Fla., March 12, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making world class robotic surgery affordable and accessible to a global...
Source: https://incomestatements.info
Category: Stock Reports